Why is Biofil Chemicals falling/rising?

As of 16-Jul, Biofil Chemicals & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 46.00, which represents a decrease of Rs 1.4 or 2.95%. The stock has underperformed its sector by 2.68% today, having touched an intraday low of Rs 45.28, reflecting a drop of 4.47%. Over the past week, the stock has decreased by 3.66%, and it has shown a significant decline of 19.30% year-to-date. The company's long-term fundamentals are weak, with a -20.95% CAGR growth in operating profits over the last five years and a low return on equity of 4.50%. Additionally, the company has reported flat results with a net sales decline of 33.62% over the past nine months, contributing to its negative performance. In the broader market context, the stock's recent performance contrasts sharply with the Sensex, which has gained 1.02% over the past month and 5.75% year-to-date. This indicates that while the overall market is experiencing growth, Biofil Chemicals is struggling significantly, having generated a return of -29.77% over the past year. The stock's trading below all its moving averages further highlights its underperformance. Despite a rise in investor participation, the liquidity remains low, and the stock is trading at a discount compared to its peers, which may not be enough to offset the negative sentiment surrounding its financial health and operational performance.